[go: up one dir, main page]

ATE240737T1 - Topische bisphosphonate zur verhinderung der knochenresorption - Google Patents

Topische bisphosphonate zur verhinderung der knochenresorption

Info

Publication number
ATE240737T1
ATE240737T1 AT97902554T AT97902554T ATE240737T1 AT E240737 T1 ATE240737 T1 AT E240737T1 AT 97902554 T AT97902554 T AT 97902554T AT 97902554 T AT97902554 T AT 97902554T AT E240737 T1 ATE240737 T1 AT E240737T1
Authority
AT
Austria
Prior art keywords
bisphosphonates
bone resorption
topical
prevent bone
bone
Prior art date
Application number
AT97902554T
Other languages
English (en)
Inventor
Itzhak Binderman
Avinoam Yaffe
Original Assignee
Itzhak Binderman
Avinoam Yaffe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603125.7A external-priority patent/GB9603125D0/en
Application filed by Itzhak Binderman, Avinoam Yaffe filed Critical Itzhak Binderman
Application granted granted Critical
Publication of ATE240737T1 publication Critical patent/ATE240737T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT97902554T 1996-02-14 1997-02-12 Topische bisphosphonate zur verhinderung der knochenresorption ATE240737T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1163296P 1996-02-14 1996-02-14
GBGB9603125.7A GB9603125D0 (en) 1996-02-15 1996-02-15 Topical bisphosphonates for prevention of bone resorption
PCT/IL1997/000050 WO1997029754A1 (en) 1996-02-14 1997-02-12 Topical bisphosphonates for prevention of bone resorption

Publications (1)

Publication Number Publication Date
ATE240737T1 true ATE240737T1 (de) 2003-06-15

Family

ID=26308705

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97902554T ATE240737T1 (de) 1996-02-14 1997-02-12 Topische bisphosphonate zur verhinderung der knochenresorption

Country Status (9)

Country Link
EP (1) EP0886521B1 (de)
JP (1) JP2000504718A (de)
AT (1) ATE240737T1 (de)
AU (1) AU723516B2 (de)
CA (1) CA2245793A1 (de)
DE (1) DE69722190T2 (de)
ES (1) ES2197329T3 (de)
HK (1) HK1016067A1 (de)
WO (1) WO1997029754A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0824341A4 (de) * 1995-05-12 1999-07-07 Merck & Co Inc Vorbeugung gegen zahnverlust durch verabreichung von alendronat oder dessen salze
CN1191833C (zh) 1999-11-25 2005-03-09 山之内制药株式会社 牙周病治疗药
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
AU2001287260A1 (en) * 2000-07-12 2002-01-21 Ecole Polytechnique Federale De Lausanne (Epfl) Active biocoating for bone implant
EP2055297A1 (de) * 2007-11-05 2009-05-06 Merz Pharma GmbH & Co. KGaA Behandlungsverfahren zur Rückfärbung von Haaren mittels Bisphosphonaten durch physiologische Repigmentierung bei aus Altersgründen oder vorzeitig ergrauten Patienten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74617A (en) * 1985-03-15 1988-11-15 Yeda Res & Dev Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
US5002769A (en) * 1987-03-13 1991-03-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for the sustained-release of chlorhexidine
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
JP3411690B2 (ja) * 1994-09-21 2003-06-03 帝人株式会社 局所投与用アレンドロン酸ナトリウム製剤

Also Published As

Publication number Publication date
DE69722190T2 (de) 2004-05-27
AU723516B2 (en) 2000-08-31
EP0886521B1 (de) 2003-05-21
ES2197329T3 (es) 2004-01-01
EP0886521A1 (de) 1998-12-30
JP2000504718A (ja) 2000-04-18
WO1997029754A1 (en) 1997-08-21
DE69722190D1 (de) 2003-06-26
HK1016067A1 (en) 1999-10-29
AU1616197A (en) 1997-09-02
CA2245793A1 (en) 1997-08-21

Similar Documents

Publication Publication Date Title
FI110667B (fi) Menetelmä farmaseuttisen valmisteen valmistamiseksi
BR9805326A (pt) Composição com liberação controlada, e, processos para controlar a liberação de compostos biologicamente ativos e controlar ou inibir o crescimento de pragas em um local.
FI964213L (fi) Bisfosfonaattien käyttö luun imeytymisen estämiseksi ortopedisen proteesin istutuksen jälkeen
ZA947338B (en) Use of angiotensin II and analogs thereof in tissue repair
AR003938A1 (es) Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos.
DE69533813D1 (de) Formulierungen und Verfahren zur Verminderung von Hautirritationen
DE69427345D1 (de) Verwendung von bisphosphonaten in der knochenchirurgie
ES2129485T3 (es) Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion.
NZ272608A (en) Inhibiting bone loss by administering a bisphosphonate and a second compound selected from various compounds, including 2-phenyl-3-aroylbenzothienes; bisphosphonate combination salts
RU93054017A (ru) Способ лечения остеопороза, композиция для лечения остеопороза, применение активно действующего на кости фосфоната и эстрогенного гормона для лечения остеопороза
DE69501419D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
BG100911A (en) Biophosphonic acids-sontaining wet-granulated form
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
ATE240737T1 (de) Topische bisphosphonate zur verhinderung der knochenresorption
FI945595L (fi) Tiosubstituoituja typpipitoisia heterosyklisiä fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi
MX9301298A (es) Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2163528T3 (es) Una solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.
NO993435L (no) Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon
BR9707770C1 (pt) Tifluzamida com eficácia aperfeiçoada
NO944500L (no) Tiosubstituerte cykliske fosfonatforbindelser for å behandle unormal kalsium- og fosfatmetabolisme
MX9206088A (es) Inhibicion de la formacion de olor y de desarrollo bacteriano.
FI945592L (fi) Fosfonosulfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi
DK0876144T3 (da) Terapeutiske anti-astmamidler indeholdende organiske selenforbindelser
DK0520372T3 (da) Inositol-phosphat-analoger som calciumantagonistiske stoffer
FI954721A0 (fi) Luuresorptiota inhiboivat sykliset yhdisteet ja koostumukset

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties